KRAS and non-small cell lung carcinoma: We found that PGE2 was strongly reduced upon ACSL3 knockdown in a panel of NSCLC cell lines harboring KRAS mutations, namely A549, A427, H1264, and H358, and this coincided with decreased cell proliferation (Fig. 1d, e and Supplementary Fig. 1C).